385 related articles for article (PubMed ID: 25341657)
1. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
Sho M; Murakami Y; Motoi F; Satoi S; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Kurata M; Fukumoto T; Akahori T; Kinoshita S; Nagai M; Nishiwada S; Unno M; Yamaue H; Nakajima Y
J Gastroenterol; 2015 Jun; 50(6):694-702. PubMed ID: 25341657
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma.
Komo T; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Urabe K; Takahashi S; Sueda T
Ann Surg Oncol; 2016 Jun; 23(6):2019-27. PubMed ID: 26856722
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis.
Paiella S; Sandini M; Gianotti L; Butturini G; Salvia R; Bassi C
Eur J Surg Oncol; 2016 May; 42(5):616-24. PubMed ID: 26916137
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
5. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer.
Okada K; Uemura K; Kondo N; Sumiyoshi T; Seo S; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Murakami Y; Takahashi S
Pancreatology; 2021 Apr; 21(3):606-612. PubMed ID: 33648880
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors for pancreatic head cancer according to para-aortic lymph node.
Lin JY; Zhang XM; Kou JT; Fa H; Zhang XX; Dai Y; He Q
Cancer Med; 2016 Oct; 5(10):2701-2707. PubMed ID: 27541833
[TBL] [Abstract][Full Text] [Related]
7. [The effect of para-aortic lymph node metastasis on the resectability of pancreatic cancer].
Dai HM; Hong XF; Pang HY; Wu WM; Zhao YP
Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):68-71. PubMed ID: 30612394
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.
Imai H; Doi R; Kanazawa H; Kamo N; Koizumi M; Masui T; Iwanaga Y; Kawaguchi Y; Takada Y; Isoda H; Uemoto S
Int J Clin Oncol; 2010 Jun; 15(3):294-300. PubMed ID: 20232101
[TBL] [Abstract][Full Text] [Related]
10. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis.
Asaoka T; Miyamoto A; Maeda S; Hama N; Tsujie M; Ikeda M; Sekimoto M; Nakamori S
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):75-80. PubMed ID: 29428109
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasis].
Otake H; Takizawa K; Nagaro H; Toge K; Hirose Y; Ishikawa H; Miura K; Ichikawa H; Hanyu T; Nagahashi M; Shimada Y; Ishikawa T; Sakata J; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2002-2004. PubMed ID: 35045474
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of para-aortic lymph node metastases in non-pancreatic periampullary cancer.
Hempel S; Oehme F; Müssle B; Aust DE; Distler M; Saeger HD; Weitz J; Welsch T
World J Surg Oncol; 2020 Jan; 18(1):16. PubMed ID: 31964383
[TBL] [Abstract][Full Text] [Related]
14. Risk factors related to metastasis of para-aortic lymph nodes in pancreatic ductal adenocarcinoma: A retrospective observational study.
Zhang X; Zhang J; Fan H; Liu Y; He Q
Medicine (Baltimore); 2018 Oct; 97(40):e12370. PubMed ID: 30290595
[TBL] [Abstract][Full Text] [Related]
15. Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features.
Agalianos C; Gouvas N; Papaparaskeva K; Dervenis C
HPB (Oxford); 2016 Aug; 18(8):633-41. PubMed ID: 27485057
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of paraaortic lymph node metastases in patients with ductal adenocarcinoma of the pancreatic head.
Petrova E; Mazzella E; Trojan J; Koch C; Schulze F; Bechstein WO; Schnitzbauer AA
Eur J Surg Oncol; 2023 May; 49(5):996-1000. PubMed ID: 36586788
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
18. Unexpected Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: a Contraindication to Resection?
Kim JS; Hwang HK; Lee WJ; Kang CM
J Gastrointest Surg; 2020 Dec; 24(12):2789-2799. PubMed ID: 31792906
[TBL] [Abstract][Full Text] [Related]
19. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
[Next] [New Search]